• Mashup Score: 5

    Background and Objectives The safety and efficacy of tenecteplase (TNK) in patients with tandem lesion (TL) stroke is unknown. We performed a comparative analysis of TNK and alteplase in patients with TLs. Methods We first compared the treatment effect of TNK and alteplase in patients with TLs using individual patient data from the EXTEND-IA TNK trials. We evaluated intracranial reperfusion at…

    Tweet Tweets with this article
    • According to this study, #tenecteplase is associated with similar rates of intracranial reperfusion, functional outcome, mortality, and symptomatic intracranial hemorrhage compared with alteplase, in patients with acute #stroke due to tandem lesions. https://t.co/xDLrRqpN7c https://t.co/6gcx2kysUH

  • Mashup Score: 7

    Olivier Fain Department of Internal Medicine, Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Antoine, Paris, France (O.F.). UPMC University Paris 06, Paris, France (O.F.). Sorbonne Universités, UPMC University Paris 06, INSERM U938, Centre de Recherche Saint-Antoine (CRSA), Paris, France (O.F.). Search for more papers by…

    Tweet Tweets with this article
    • #STROKE #StrokeImages Bradykinin-mediated #angioedema following #Tenecteplase administration in an acute ischemic stroke https://t.co/rCsjs5r6Hi https://t.co/PxXUOpGLmq

  • Mashup Score: 2

    The rate of symptomatic hemorrhage after getting a thrombolytic is half that with tenecteplase than with alteplase.

    Tweet Tweets with this article
    • Patients with an ischemic stroke treated with #tenecteplase have almost a 50% lower rate of symptomatic intracranial hemorrhage compared with those receiving alteplase. https://t.co/0wdD8kBEVj #ISC2022 https://t.co/bPACUrtAOp

  • Mashup Score: 1

    The rate of symptomatic hemorrhage after getting a thrombolytic is half that with tenecteplase than with alteplase.

    Tweet Tweets with this article
    • Patients with an ischemic stroke treated with #tenecteplase have almost a 50% lower rate of symptomatic intracranial hemorrhage compared with those receiving alteplase. https://t.co/e4suEl8pJw #ISC2022 https://t.co/VpLYnydvbU

  • Mashup Score: 7

    Purpose of Review Tenecteplase has been studied and recommended as an alternative thrombolytic agent in patients with acute stroke. A brief review of clinical trials and guidelines pertinent to our clinical decision algorithm is described. This is followed by operational steps that were made to create and implement a clinical pathway based on available evidence in which tenecteplase is used in…

    Tweet Tweets with this article
    • Early Experience With #Tenecteplase at a Comprehensive #Stroke Center: https://t.co/gDR3JNPtHQ #NeuroTwitter https://t.co/xgp5I3uBFd

  • Mashup Score: 0

    The rate of symptomatic hemorrhage after getting a thrombolytic is half that with tenecteplase than with alteplase.

    Tweet Tweets with this article
    • Patients with an ischemic stroke treated with #tenecteplase have almost a 50% lower rate of symptomatic intracranial hemorrhage compared with those receiving alteplase. https://t.co/zutKU0RTyV #ISC2022 https://t.co/iBOcm8KHpk